Buy aesthetics supplies. Clarins owners take controlling stake in Pai Skincare

Lipolytics injections

THE WHAT? The family behind Clarins has upped its stake in Pai Skincare via its holding company, Famille C Participations, according to a report published by WWD.

Aesthetique medical

THE DETAILS The latest investment follows the purchase of a minority stake in the brand back in 2021, as lead investor of a US$9 million Series B investment round. With this majority share, the Clarins owner intends to boost the clean skin care brand’s e-commerce channel.

THE WHY? Prisca Courtin, CEO of Famille C Participations told WWD, “It’s time for Pai to accelerate in its country of origin, which is the UK, and to develop in Europe.”

Buying aesthetics supplies typically involves sourcing these items from licensed distributors, manufacturers, or specialized suppliers who cater specifically to the needs of aesthetic professionals. These supplies are integral to performing aesthetic treatments aimed at enhancing skin appearance, addressing various skin concerns, and improving overall beauty and wellness.

Examples of aesthetics supplies include:

  • Dermal Fillers: Injectable substances used to add volume and reduce wrinkles.

  • Botulinum Toxin (Botox): Injectables used to temporarily relax facial muscles and reduce wrinkles.

  • Laser Devices: Equipment used for hair removal, skin rejuvenation, tattoo removal, and other laser treatments.

  • Chemical Peels: Solutions applied to the skin to exfoliate and improve texture.

  • Microdermabrasion Devices: Tools used for mechanical exfoliation to rejuvenate skin.

  • Microneedling Devices: Devices that create tiny punctures in the skin to stimulate collagen production.

  • Cosmeceuticals: Skincare products that contain biologically active ingredients with pharmaceutical-like benefits.

  • Sterilization and Disinfection Products: Essential for maintaining hygiene and preventing infections in clinical settings.

  Buy aesthetics supplies. Unilever beats Q1 sales forecasts; CEO Alan Jope denies profiting off the cost-of-living crisis  

Leave a Reply